Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same
US10071100B2 · kind B2 · utility
2Cited by
54References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2018 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Jan 3, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid and a therapeutic agent (1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea), or pharmaceutically acceptable salts thereof, and a polymer. Other aspects include methods of making and using such nanoparticles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.